Cure My Disease

Don't miss your cure!

 Log in / Sign up

New eye drop trial targets common, irritating eyelid condition

NCT ID NCT06720896

Recruiting now Disease control Sponsor: Aperta Biosciences, LLC Source: ClinicalTrials.gov ↗

Summary

This study is testing a new eye drop treatment called APT-001 for people with blepharitis, a condition that causes red, irritated, and crusty eyelids. About 100 participants will be randomly assigned to receive either the real treatment or a control substance (with no active drug) for 43 days to see which is better at clearing symptoms and is safe. The main goal is to see if the treatment can cure the crusty buildup (collarettes) on the eyelids.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLEPHARITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dr. Rudy Gutierrez Diaz Sede Central

    RECRUITING

    Guatemala City, Guatemala

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • EyeScan, Imágenes Diagnósticas Oculares, S. A.

    RECRUITING

    Guatemala City, Guatemala

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

BLEPHARITIS